Zbtb7 suppresses the expression of CDK2 and E2F4 in liver cancer cells: Implications for the role of Zbtb7 in cell cycle regulation

Molecular Medicine Reports

Volumn 5, Issue 6, 2012, Pages 1475-1480

  Yang, Xuefeng ^a   Zu, Xuyu ^a,b   Tang, Jing ^a   Xiong, Wei ^a   Zhang, Yuan ^a   Liu, Feng ^b   Jiang, Yuyang ^b,c  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b TSINGHUA UNIVERSITY   (China)

^c Tsinghua University   (China)

Author keywords

CDK2; Cell cycle regulation; E2F4; Promoter activity; Zbtb7

Indexed keywords

CYCLIN DEPENDENT KINASE 2; MESSENGER RNA; PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F4; UNCLASSIFIED DRUG; ZBTB7 PROTEIN;

ARTICLE; CELL CYCLE REGULATION; CELL STRAIN HEPG2; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING;

CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE 2; DNA-BINDING PROTEINS; DOWN-REGULATION; E2F4 TRANSCRIPTION FACTOR; G1 PHASE CELL CYCLE CHECKPOINTS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 84860764316     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.846     Document Type: Article

References (18)

1. Davies JM, Hawe N, Kabarowski J, et al: Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 18: 365-375, 1999. (Pubitemid 29060612)
2. Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C, Teruya-Feldstein J and Pandolfi PP: Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433: 278-285, 2005.
3. Kukita A, Kukita T, Ouchida M, Maeda H, Yatsuki H and Kohashi O: Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood 94: 1987-1997, 1999. (Pubitemid 29430415)
4. Morrison DJ, Pendergrast PS, Stavropoulos P, Colmenares SU, Kobayashi R and Hernandez N: FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein. Nucleic Acids Res 27: 1251-1262, 1999. (Pubitemid 29206432)
5. Lee DK, Suh D, Edenberg HJ and Hur MW: POZ Domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1. J Biol Chem 277: 26761-26768, 2002. (Pubitemid 34951680)
6. Apostolopoulou K, Pateras IS, Evangelou K, Tsantoulis PK, Liontos M, Kittas C, Tiniakos DG, Kotsinas A, Cordon-Cardo C and Gorgoulis VG: Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. J Pathol 213: 294-302, 2007. (Pubitemid 350074019)
7. Maeda T, Merghoub T, Hobbs RM, Dong L, Maeda M, Zakrzewski J, van den Brink MR, Zelent A, Shigematsu H, Akashi K, Teruya-Feldstein J, Cattoretti G and Pandolfi PP: Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRF. Science 316: 860-866, 2007. (Pubitemid 46764272)
8. Laudes M, Bilkovski R, Oberhauser F, Droste A, Gomolka M, Leeser U, Udelhoven M and Krone W: Transcription factor FBI-1 acts as a dual regulator in adipogenesis by coordinated regulation of cyclin-A and E2F-4. J Mol Med 86: 597-608, 2008.
9. Choi WI, Jeon BN, Park H, Yoo JY, Kim YS, Koh DI, Kim MH, Kim YR, Lee CE, Kim KS, Osborne TF and Hur MW: Proto-oncogene FBI-1 (Pokemon) and SREBP-1 synergistically activate transcription of fatty-acid synthase gene (FASN). J Biol Chem 832: 29341-29354, 2008.
10. Jeon BN, Yoo JY, Choi W, Lee CE, Yoon HG and Hur MW: Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb Gene via binding competition with Sp1 and recruitment of co-repressors. J Biol Chem 283: 33199-33210, 2008.
11. Pessler F and Hernandez N: Flexible DNA Binding of the BTB/POZ-domain Protein FBI-1. J Biol Chem 278: 29327-29335, 2003. (Pubitemid 36935849)
12. Shiffman D, Brooks EE, Brooks AR, Chan CS and Milner PG: Characterization of the human cyclin-dependent kinase 2 gene. Promoter analysis and gene structure. J Biol Chem 271: 12199-12204, 1996. (Pubitemid 26160879)
13. Ekholm SV and Reed SI: Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 12: 676-684, 2002.
14. Adachi N and Lieber MR: Bidirectional gene organization: a common architectural feature of the human genome. Cell 109: 807-809, 2002. (Pubitemid 34785996)
15. Ginsberg D, Vairo G, Chittenden T, Xiao Z-X, Xu G, Wydner KL, DeCaprio JA, Lawrence JB and Livingston MD: E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev 8: 2665-2679, 1994. (Pubitemid 24375417)
16. Beijersbergen RL, Kerkhoven RM, Zhu L, Carlee L,Voorhoeve PM and Bernards R: E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev 8: 2680-2690, 1994. (Pubitemid 24375418)
17. Singh P, Wong SH and Hong W: Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J 13: 3329-3338, 1994. (Pubitemid 24226948)
18. Xu G, Livingston DM and Krek W: Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl Acad Sci USA 92: 1357-1361, 1995.